Genitourinary Cancers | Specialty

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research.

High-Risk Renal Cell Carcinoma Treatment

June 25th 2014

Introduction and Frontline Treatment of RCC

June 25th 2014

New Methods of Boosting Response to Bladder Cancer Immunotherapy Explored

June 18th 2014

Although bacillus Calmette-GuÃ©rin (BCG) therapy has significantly improved outcomes for patients with nonâ€“muscle invasive bladder cancer since its introduction nearly 40 years ago, there is a pressing need to enhance responses to BCG and to distinguish which patients would respond to treatment early on in the course of therapy.

Dr. Figlin on Advances in Immunotherapy for Kidney Cancer

June 6th 2014

Robert Figlin, MD, FACP, Professor of Medicine and Biomedical Sciences, Steven Spielberg Family Chair in Hematology Oncology, Cedars-Sinai Medical Center, discusses recent advances in the field of immunotherapy for kidney cancer.

Investigational Immunotherapy Granted First Breakthrough Therapy Designation in Bladder Cancer

June 1st 2014

MPDL3280A reduced tumors in 43% of patients with previously treated PD-L1-positive metastatic bladder cancer, resulting in the first breakthrough therapy designation from the FDA for a treatment in this setting.

Role of Urologists in Advanced Prostate Cancer Clinics

May 28th 2014

Role of Nurses and Other Care Providers

May 28th 2014

SREs, Risk Stratification, and Agents in Development

May 28th 2014

Treatment Advances in Metastatic CRPC

May 28th 2014

Sipuleucel-T in Castration-Resistant Prostate Cancer

May 28th 2014

Radium-223: Treatment Considerations

May 28th 2014

Antiandrogens-Differences and Sequencing

May 28th 2014

Treating mCRPC with Newer Hormonal Agents

May 28th 2014

Oral Hormonal Agents for mCRPC

May 28th 2014

Treating Symptomatic Bone Metastatic CRPC

May 28th 2014

Multidisciplinary Approach to mCRPC Treatment

May 28th 2014

Evolution of Treatment for mCRPC

May 28th 2014

Biomarkers in the Management of Prostate Cancer

May 28th 2014

Biopsy, Biomarkers, and Imaging in Prostate Cancer

May 28th 2014

Prognostic Biomarker Tests for Prostate Cancer

May 28th 2014